NEW YORK, Nov. 11, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.      

TG Therapeutics, Inc. (NASDAQCM: TGTX)
Class Period: June 4, 2018 to September 25, 2018
Lead Plaintiff Deadline: December 3, 2018

During the class period, TG Therapeutics, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) TG was involved in cleaning the data collected in the UNITY-CLL Trial; and as a result, was able to gain an understanding as to the efficacy of the combination therapy; (2) as a result of that data cleaning, TG knew the UNITY-CLL Trial had failed to meet its stated goal and as a result, the Company would not be able to seek accelerated approval; and (3) given that the UNITY-CLL Trial had failed to meet its stated goal, it was highly unlikely that the combination therapy would meet its primary endpoint of increased progression free survival.

Get additional information about the TGTX lawsuit: http://www.kleinstocklaw.com/pslra-1/tg-therapeutics-inc-loss-submission-form?wire=3

Adient plc (NYSE: ADNT)
Class Period: October 31, 2016 to June 11, 2018
Lead Plaintiff Deadline: December 3, 2018

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements. In particular, the complaint alleges that defendants repeatedly stressed to investors that the Company was “solidly on track” to deliver 200-basis-point margin expansion by 2020, which was largely dependent on operational and financial improvements in Adient’s core SS&M business, while unbeknownst to investors, Adient’s core SS&M business faced significant operational problems such that the repeatedly touted 200-basis-point margin expansion was not “on track” at any point during the Class Period. Consequently, Adient stock traded at artificially inflated prices during the Class Period, reaching a high of $85.93 per share.

Get additional information about the ADNT lawsuit: http://www.kleinstocklaw.com/pslra-1/adient-plc-loss-submission-form?wire=3

Alphabet Inc. (NASDAQ: GOOG)
Class Period: April 24, 2018 to October 10, 2018
Lead Plaintiff Deadline: December 10, 2018

The lawsuit alleges Alphabet Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) Google exposed the private data of hundreds of thousands of Google+ social network users; (2) Google actively concealed this data breach for several months; (3) this conduct violated Google’s purported data privacy and security policies; (4) discovery of the foregoing conduct could foreseeably subject Alphabet to heightened regulatory scrutiny; and (5) as a result, Alphabet’s public statements were materially false and misleading at all relevant times.

Get additional information about the GOOG lawsuit: http://www.kleinstocklaw.com/pslra-1/alphabet-inc-loss-submission-form?wire=3

India Globalization Capital Inc. (NYSE American: IGC)
Class Period: October 25, 2017 to October 29, 2018
Lead Plaintiff Deadline: January 2, 2019

According to the complaint, India Globalization Capital Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) India Globalization’s business model was in a state of change in order to lure potential blockchain and cannabis investors; (2) India Globalization had overstated the benefits of its relationships with manufacturers, partners, and distributors in order to inflate the Company’s potential commercial success in the blockchain and cannabis markets; (3) as a result, the NYSE delisted India Globalization’s shares from their exchange; and (4) consequently, Defendants’ statements about India Globalization’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.  On October 29, 2018 India Globalization announced that NYSE Regulation would begin the process of delisting the Company and trading would halt immediately.

Get additional information about the IGC lawsuit: http://www.kleinstocklaw.com/pslra-1/india-globalization-capital-inc-loss-submission-form?wire=3

Align Technology, Inc. (NASDAQGS: ALGN)
Class Period: July 25, 2018 to October 24, 2018
Lead Plaintiff Deadline: January 4, 2019

The complaint alleges Align Technology, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company would offer higher discounts to promote Invisalign; (2) the promotions would materially impact revenue; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.  On October 24, 2018, Align Technology issued a press release announcing its Q3 2018 financial results. Therein, the Company disclosed a more than 6% decrease in its Invisalign Average Selling Price (“ASP”). On the same day, the Company also announced that its Chief Marketing Officer would “reduce his responsibilities and transition to a part-time position.” On this news, Align Technology’s share price shares fell $58.76 to close at $232.07 on October 25, 2018, thereby injuring investors.

Get additional information about the ALGN lawsuit: http://www.kleinstocklaw.com/pslra-1/align-technology-inc-loss-submission-form?wire=3

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com